Bisphenol A

Where the papers sit

10 papers from the last 6 months study Bisphenol A directly · updated from PubMed 6 Oct 2026

• Bisphenol a Toxicity Mechanisms

  Oxidative stress, inflammation and metabolic disruption recur across BPA-linked diabetes, airway injury, liver disease and thyroid carcinogenesis. Multi-omics and network toxicology are converging on targets such as NQO1 and the PTEN/PI3K/AKT axis. Immune-microenvironment damage, impaired repair and disulfidptosis extend the mechanisms beyond isolated organ toxicity. The work is moving toward pathway-based biomarkers and targeted protective interventions.

  6 papers · 60%

• Computational Disease Biomarkers

  Transcriptomic signatures and computational prioritization are being used to connect cell-state changes with clinically relevant disease markers. T-cell depletion and monocyte-associated signals define the lupus analysis, while network and single-cell methods examine BPA-linked clear-cell renal cell carcinoma. Differential expression, machine learning and molecular docking recur as complementary tools. The evidence supports candidate discovery, but validation of diagnostic or prognostic value remains open.

  2 papers · 20%

• Bisphenol a Detection Technologies

  BPA measurement is shifting toward rapid, portable and multimodal sensing rather than conventional laboratory readouts alone. Smartphone-assisted and spectrophotometric colorimetry use enzymeless nanosensors to improve practical detection. HCR amplification and CRISPR/Cas12a add logic-gate discrimination and dual-analyte capability, with kanamycin included as a target. Detection limits, readout reliability and performance in water or biological specimens remain the key tests.

  2 papers · 20%